Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

2020 New England Journal of Medicine 3,109 citations

Abstract

In this trial involving high-risk persons, lung-cancer mortality was significantly lower among those who underwent volume CT screening than among those who underwent no screening. There were low rates of follow-up procedures for results suggestive of lung cancer. (Funded by the Netherlands Organization of Health Research and Development and others; NELSON Netherlands Trial Register number, NL580.).

Keywords

Lung cancerComputed tomographicRandomized controlled trialLung cancer screeningMedicineRadiologyCancerClinical trialComputed tomographyNuclear medicineOncologyInternal medicine

Affiliated Institutions

Related Publications

Risk‐based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch‐Belgian randomised lung cancer multi‐slice CT screening trial (NELSON)

Abstract A method to obtain the optimal selection criteria, taking into account available resources and capacity and the impact on power, is presented for the Dutch‐Belgian rand...

2006 International Journal of Cancer 484 citations

Publication Info

Year
2020
Type
article
Volume
382
Issue
6
Pages
503-513
Citations
3109
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

3109
OpenAlex

Cite This

Harry J. de Koning, Carlijn M. van der Aalst, Pim A. de Jong et al. (2020). Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. New England Journal of Medicine , 382 (6) , 503-513. https://doi.org/10.1056/nejmoa1911793

Identifiers

DOI
10.1056/nejmoa1911793